Cargando…
Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. However, other non-dopaminergic neuronal systems such as the serotonergic system are also involved. Serotonergic dysfunction is associated with non-motor symptoms and complications, inc...
Autores principales: | Muñoz, Ana, Lopez-Lopez, Andrea, Labandeira, Carmen M., Labandeira-Garcia, Jose L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289026/ https://www.ncbi.nlm.nih.gov/pubmed/32581728 http://dx.doi.org/10.3389/fnana.2020.00026 |
Ejemplares similares
-
Neurotransmitter Interactions in the Basal Ganglia
por: Finkbeiner, Steven M.
Publicado: (1987) -
Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
por: Lopez-Lopez, Andrea, et al.
Publicado: (2023) -
Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
por: Miguelez, Cristina, et al.
Publicado: (2017) -
L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019) -
The effects of cues on neurons in the basal ganglia in Parkinson's disease
por: Sarma, Sridevi V., et al.
Publicado: (2012)